L

Lysosomal Therapeutics Inc.

10 employees

Lysosomal Therapeutics deliver cures for neurodegenerative diseases.

Investor insights

Sectors invested in

Biotechnology4

Medical2

Pharmaceutical2

Health Care2

Translational Cancer Genomics and Cancer Research1

Multiplexed Molecular Diagnostic Development1

Digital Genomics for Pathway-based Research1

Gene Expression1

General Purpose Reagents for Laboratory Use1

Health Diagnostics1

Amyotrophic Lateral Sclerosis1

Neurodegenerative Diseases1

ALS1

Alzheimer's1

Alzheimer's Disease1

Neuroscience1

drug development1

research1

nanotechnology1

biotechnology1

Funding rounds participated in

$15M sweet spot round size

Most of their 4 investments are in rounds between $5M and $20M

Basic info

Sectors

Biotechnology

Health Care

Therapeutics

Date founded

2011

Investments made

A

Amylyx Pharmaceuticals raised $5M on August 22, 2016

Investors: ALS Investment Fund and Lysosomal Therapeutics Inc.

A

Artax Biopharma Inc raised $10M on September 22, 2015

Investors: Advent Life Sciences and Lysosomal Therapeutics Inc.

A

Aura Biosciences raised $21M on March 5, 2015

Investors: Chiesi Ventures, Ysios Capital, Advent Life Sciences, Pappas Ventures, LI-COR Biosciences and Lysosomal Therapeutics Inc.

N

NanoString Technologies, Inc. raised $20M on November 7, 2011

Investors: OVP Venture Partners, Clarus Ventures, LLC and Lysosomal Therapeutics Inc.

Funding rounds raised

Total raised

$20M

from 8 investors over 8 rounds

L

Lysosomal Therapeutics Inc. raised $20M on February 3, 2015

Investors: Sanofi Ventures, Lilly Ventures, Partners HealthCare and Atlas Venture

L

Lysosomal Therapeutics Inc. raised $4.8M on May 12, 2014

Investors: Sanofi Ventures, Atlas Venture, Lilly Ventures and Partners HealthCare